Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001104659-23-067625
Filing Date
2023-06-02
Accepted
2023-06-02 16:46:31
Documents
2
Group Members
ALEX NOAH INVESTORS, INC.JONATHAN I. COPEJOSHUA B. SCHEINFELDLINCOLN PARK CAPITAL, LLCROCKLEDGE CAPITAL CORP

Document Format Files

Seq Description Document Type Size
1 SC 13G tm2317715d1_sc13g.htm SC 13G 107718
2 EXHIBIT 99.1 tm2317715d1_ex99-1.htm EX-99.1 12008
  Complete submission text file 0001104659-23-067625.txt   121556
Mailing Address 4350 LA JOLLA VILLAGE DRIVE SUITE 800 San Diego CA 92122
Business Address 4350 LA JOLLA VILLAGE DRIVE SUITE 800 San Diego CA 92122 858-550-0780
Tracon Pharmaceuticals, Inc. (Subject) CIK: 0001394319 (see all company filings)

EIN.: 342037594 | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-88629 | Film No.: 23989665
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 440 NORTH WELLS STREET SUITE 410 CHICAGO IL 60654
Business Address 440 NORTH WELLS STREET SUITE 410 CHICAGO IL 60654 312-822-9300
Lincoln Park Capital Fund, LLC (Filed by) CIK: 0001592644 (see all company filings)

EIN.: 010939472 | State of Incorp.: IL | Fiscal Year End: 1231
Type: SC 13G